Intravitreal pegaptanib sodium (Macugen®) for diabetic macular oedema

Acta Ophthalmologica

Volumn 87, Issue 6, 2009, Pages 623-630

  Querques, Giuseppe ^a   Bux, Anna V ^a   Martinelli, Domenico ^b   Iaculli, Cristiana ^a   Noci, Nicola D ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Diabetic macular oedema; Laser photocoagulation; Macugen ; Optical coherence tomography; Pegaptanib sodium

Indexed keywords

MAGUGEN; PEGAPTANIB; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; DIABETIC MACULAR EDEMA; FEMALE; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; APTAMERS, NUCLEOTIDE; DIABETIC RETINOPATHY; EYEGLASSES; FEMALE; FOLLOW-UP STUDIES; FOVEA CENTRALIS; HUMANS; INJECTIONS; MACULA LUTEA; MACULAR EDEMA; MALE; MIDDLE AGED; PHOTORECEPTOR CELLS, VERTEBRATE; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 69449105638     PISSN: 1755375X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01580.x     Document Type: Article

References (39)

1. Aiello LP (2005 Angiogenic pathways in diabetic retinopathy. N Engl J Med 353 : 839 841.
2. Antcliff RJ Marshall J (1999 The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol 14 : 223 232.
3. Antonetti DA, Wolpert EB, DeMaio L, Harhaj NS Scaduto RC Jr. (2002 Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem 80 : 667 677.
4. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H et al. (2007 Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 114 : 743 750.
5. Audren F, Erginay A, Haouchine B, Benosman R, Conrath J, Bergmann JF, Gaudric A Massin P (2006 Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial. Acta Ophthalmol Scand 84 : 624 630. (Pubitemid 44317541)
6. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA Giust MJ (2006 Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113 : 363 372.
7. Bandello F, Lanzetta P Menchini U (1999 When and how to do a grid laser for diabetic macular edema. Doc Ophthalmol 97 : 415 419.
8. Bhisitkul RB (2006 Vascular endothelial growth factor biology: clinical implications for ocular treatments. Br J Ophthalmol 90 : 1542 1547.
9. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S the ANCHOR Study Group (2006 Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355 : 1432 1444.
10. Chun DW, Heier JS, Topping TM, Duker JS Bankert JM (2006 A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology 113 : 1706 1712.
11. Ciulla TA, Amador AG Zinman B (2003 Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 26 : 2653 2664.
12. Costa RA, Calucci D, Skaf M, Cardillo JA, Castro JC, Melo LA Jr., Martins MC Kaiser PK (2004 Optical coherence tomography 3: automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. Invest Ophthalmol Vis Sci 45 : 2399 2406.
13. Cunningham ET Jr., Adamis AP, Altaweel M et al. the Macugen Diabetic Retinopathy Study Group (2005 A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112 : 1747 1757.
14. Diabetic Retinopathy Clinical Research Network, Browning DJ, Glassman AR, Aiello LP et al. (2007a Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 114 : 525 536.
15. Diabetic Retinopathy Clinical Research Network, Scott IU, Edwards AR, Beck RW et al. (2007b A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 114 : 1860 1867.
16. Drolet DW, Nelson J, Tucker CE et al. (2000 Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys. Pharm Res 17 : 1503 1510.
17. Eandi CM, Chung JE, Cardillo-Piccolino F Spaide RF (2005 Optical coherence tomography in unilateral resolved central serous chorioretinopathy. Retina 25 : 417 421.
18. Early Treatment Diabetic Retinopathy Study Research Group (1985 Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103 : 1796 1806.
19. Early Treatment Diabetic Retinopathy Study Research Group (1991 Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 98 : 766 785.
20. Fang X, Sakaguchi H, Gomi F et al. (2008 Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema. Acta Ophthalmol 86 : 800 805.
21. Ferrara N, Hillan KJ, Gerber HP Novotny W (2004 Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3 : 391 400.
22. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF Levison SW (2002 Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 47 : S253 S262.
23. Gillies MC (2006 What we don't know about Avastin might hurt us. Arch Ophthalmol 124 : 1478 1479.
24. Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H Zhu M (2006 Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113 : 1533 1538.
25. Gragoudas ES, Adamis AP, Cunningham ET Jr., Feinsod M Guyer DR (2004 Pegaptanib for neovascular age-related macular degeneration. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 : 2805 2816.
26. Haritoglou C, Kook D, Neubauer A et al. (2006 Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26 : 999 1005.
27. Iturralde D, Spaide RF, Meyerle CB et al. (2006 Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 26 : 279 284.
28. Jonas JB, Kamppeter BA, Harder B, Vossmerbaeumer U, Sauder G Spandau UH (2006 Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study. J Ocul Pharmacol Ther 22 : 200 207. (Pubitemid 44051133)
29. Massin P, Audren F, Haouchine B, Bergmann JF, Benosman R, Caulin C Gaudric A (2004 Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 111 : 218 225.
30. Mendrinos E, Donati G Pournaras CJ (2008). Rapid and persistent regression of severe new vessels on the disc in proliferative diabetic retinopathy after a single intravitreal injection of pegaptanib. Acta Ophthalmol Epub ahead of print S, Rosenfeld PJ, Puliafito CA, Marcus EN Venkatraman AS (2005 Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration. Twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 112 : 1035 1047.
31. Ota M, Tsujikawa A, Murakami T, Kita M, Miyamoto K, Sakamoto A, Yamaike N Yoshimura N (2007 Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion. Br J Ophthalmol 91 : 1644 1649.
32. Richter B Kohner E (2004 Medical interventions for diabetic retinopathy. In : Wormald R, Smeeth L Henshaw K (eds). Evidence-based ophthalmology. London : BMJ Books, 331 340.
33. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY Kim RY & the MARINA Study Group (2006 Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 : 1419 1431. (Pubitemid 44511557)
34. Sandberg MA, Brockhurst RJ, Gaudio AR Berson EL (2005 The association between visual acuity and central retinal thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci 46 : 3349 3354.
35. Soliman W, Sander B Jorgensen TM (2007 Enhanced optical coherence patterns of diabetic macular oedema and their correlation with the pathophysiology. Acta Ophthalmol Scand 85 : 613 617.
36. Soliman W, Sander B, Soliman KA, Yehya S, Rahamn MS Larsen M (2008 The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema. Acta Ophthalmol 86 : 284 291.
37. Spaide RF Fisher YL (2006 Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 26 : 275 278.
38. Starita C, Patel M, Katz B Adamis AP (2007 Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (Macugen) in diabetic retinopathy. Dev Ophthalmol 39 : 122 148.
39. Sutter FK, Simpson JM Gillies MC (2004 Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 111 : 2044 2049.